Radiation versus observation for liver spread of small cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares giving liver-directed radiation to watching closely without radiation. It is for people with small cell lung cancer that has spread to the liver, to see whether radiation helps control the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent before any study treatment or medicines
- You are age 18 to 70
- Your small cell lung cancer is confirmed by lab tests on tissue or cells
- Your cancer has spread to distant sites, including the liver
- Your general health is good enough (ECOG 0 to 2) and you’re expected to live more than 3 months
- Your blood counts, liver tests, and kidney function meet specific lab thresholds
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding radiation to the liver can make immunotherapy and chemotherapy work better for people with lung cancer that has spread to the liver. It's for patients who have already tried standard treatments, including immunotherapy, and need new options.
This study follows patients with small cell lung cancer who receive radiation therapy combined with other treatments. Researchers will track how well the treatment works and how patients respond over time to help improve future care.
This Phase 1 study tests whether targeted radiation to liver tumors combined with immunotherapy can control metastatic non-small cell lung cancer. It aims to find a safe and effective treatment approach for people whose cancer has spread to the liver.
This trial looks at whether giving additional targeted radiation to the chest can help people with extensive-stage small cell lung cancer after they finish standard chemo-immunotherapy. It may help control the cancer in the lung area and prevent it from coming back there.
This trial tests a combination of chemotherapy, immunotherapy, and targeted radiation for people with extensive-stage small-cell lung cancer. The goal is to see if adding radiation to leftover tumors after initial treatment helps control the disease better.
This trial compares two ways to manage limited-stage small cell lung cancer that has improved after initial chemotherapy and radiation. Participants will either get preventive brain radiation or have regular brain MRI scans instead, to see which approach is safer and works better.
Hear when a new Radiotherapy; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.